Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Companion Animal Drugs Market by Product Type, Animal Type, Dynamics, Competitor Analysis and Outlook to 2023


(, January 12, 2018 ) Global companion animal drugs market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of 5.6% over 2017-2023. Market for companion animal drugs projected to reach US$ XX Mn by 2023 owing to rising human and companion animals bondage by means of adoption across the globe.

Companion animal drugs market report gives comprehensive outlook on companion animal drugs market across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on companion animal drugs market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, animal type, route of administration, distribution channel, and geographic regions. This report studies companion animal drugs market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, companion animal drugs market report includes animal demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed companion animal drugs market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the companion animal drugs market report include suppliers, manufacturers, marketers, policy makers, and veterinary healthcare service providers engaged in manufacturing and supply of companion animal drug products.
Global Companion Animal Drugs Market:

For more information

Rising Pet companionship to the human beings expected to drive the companion animal drugs market over the forecast period
Companion animals have been trusted for their companionship to the human throughout the history and keeping the companion animals healthy is a top priority for caregivers everywhere in the world, which is expected to drive the companion animal market over six years forecast period. Moreover, several studies on human and companion animals' interactions showed that association with companion animals results in positive health benefits. Therefore, it is essential to veterinarians and caregivers to give utmost attention to companion animal health as companion animals are primary source of zoonotic diseases spread to humans and vice versa, this is expected to create significant market demand for companion animal drugs over the forecast period.
Increasing per pet expenditure in recent times expected to drive market revenue growth
Several respondents and pet owners reveled that pet expenditure is increasingly becoming integral part of their monthly expenditure and companion animals are part of several families across the developed and developing economies. Moreover, rising interactions between pets and human beings prompting the care givers and pet owners to adopt better healthcare services to the companion animals this is projected to drive market revenue growth over the forecast period.

North America accounted for larger market revenue share in global companion animal drugs market
U.S. market dominated the companion animal drugs market with largest market share in North America market with moderate growth rate. Europe companion animal drugs market holds significant share in global companion animal drugs market and projected to grow at significant growth over the forecast period.
Competition Assessment

Key players profiles in the global Companion Animal Drugs market include:
-Bayer AG (Germany)
-Boehringer Ingelheim GmbH (Germany)
-Ceva Santé Animale (France)
-Eli Lilly and Company (U.S)
-Hester biosciences (India)
-Merck & Co., Inc. (U.S)
-Vétoquinol S.A. (France)
-Virbac S.A. (France)
-Zoetis Inc. (U.S)

Players in the companion animal drugs market are launching the products in the market to garner larger market share. For instance, in July 2016, Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, received U.S. Food and Drug Administration's approval for BRAVECTO (fluralaner topical solution) a topical treatment for fleas and ticks for both cats and dogs.
Key Findings of the Report:

Request Sample Copy

Key Features of the Report:

-The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
-The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
-The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
-The report tracks recent innovations, key developments and startup's details that are actively working in the market
-The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
-The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation

By Product Type
o Antimicrobials
o Ectoparasiticides
o Endoparacitides
o Endectoparaciticides
o Anti-inflammatory Drugs
o Anti-Obesity Drugs
o Behavioral Products
o Biologic Drugs
o Others

By Animal Type
o Feline
o Canine
o Equine

By Route of Administration
o Oral
o Parenteral
o Topical
o Others

Distribution Channel
o Veterinary Pharmacies
o Veterinary Hospitals
o Veterinary Clinics
o E-Commerce

o North America
o Europe
-Rest of Europe
o Asia-Pacific
-Australia & New Zealand
-ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
-South Korea
-Rest of Asia-Pacific
o Latin America
-Rest of Latin America
o Middle East and Africa (MEA)
-Gulf Cooperation Council (GCC) Countries
-South Africa
Rest of MEA

Make an enquiry:

Rajat Sahni


Source: EmailWire.Com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.

GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | | i-Canada-News.Com | | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | | | | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | - Medicl Newswire and Press Release service of GroupWeb Media LLC